Neurocrine Biosciences
NBIX
NBIX
212 hedge funds and large institutions have $3.44B invested in Neurocrine Biosciences in 2016 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 85 increasing their positions, 75 reducing their positions, and 37 closing their positions.
Holders
212
Holders Change
-6
Holders Change %
-2.75%
% of All Funds
5.66%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.24%
New
35
Increased
85
Reduced
75
Closed
37
Calls
$22.7M
Puts
$16.2M
Net Calls
+$6.55M
Net Calls Change
-$1.51M
Top Buyers
1 |
SAM
1
Sectoral Asset Management
Montreal,
Quebec, Canada
|
$65.3M |
2 |
HM
2
HealthCor Management
New York
|
$28.7M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$71.7M |
4 |
4
First Trust Advisors
Wheaton,
Illinois
|
$25.2M |
5 |
5
Goldman Sachs
New York
|
$31M |